EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, ROSGQ: Rosetta Genomics Ltd

12 Nov 2025
LAST:

0.0001

CHANGE:
 0.00		OPEN:
0.0001		HIGH:
0.0001		ASK:
0.0000		VOLUME:
1.5K
CHG(%):
0.00		PREV:
0.0001		LOW:
0.0001		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Nov 250.00010.00010.00010.00011.5K
07 Nov 250.00010.00010.00010.00011.5K
03 Nov 250.00010.00010.00010.00011.6K

COMPANY PROFILE

Name:Rosetta Genomics Ltd
About:Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide. The company's microRNA technologies based diagnostic tests include RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer; mi-KIDNEY, a kidney tumor classification test for pathology samples; RosettaGX Reveal for the diagnosis of indeterminate thyroid fine-needle aspirate samples; and mi-LUNG diagnostic tests. It also provides UroVysion, a urine-based Fluorescence In Situ Hybridization (FISH) assay that is intended for use in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer; and ERG/PTEN, which are FISH-based prognostic tests in prostate cancer. In addition, the company offers ALK/ROS1 that are FISH-based predictive tests indicated for patients who are diagnosed with late stage lung cancer; and PCR gene mutation analysis for bladder, lung, colon, and melanoma patients. The company provides its diagnostic solutions for oncologists, urologists, endocrinologists, cytopathologists, and other specialists to facilitate them in serving their patients. It has a license agreement with Max Planck Innovation GmbH for the rights to its proprietary microRNAs for diagnostics and research purposes. The company also has a collaboration agreement with Meir Medical Center to develop a microRNA classifier relating to patients with non-small cell lung cancer considered for treatment with immuno oncology drugs. Rosetta Genomics Ltd. was founded in 2000 and is headquartered in Rehovot, Israel.
Sector:Healthcare
Address:10 Plaut Street, Rehovot, Israel, 76706
Website:https://www.rosettagenomics.com
CIK:0001362959
ISIN:IL0011026494
FIGI:BBG000HJC443

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.000.0%
MA10:0.000.0%
MA20:0.000.0%
Week High:0.000.0%
Week Low:0.000.0%
Month High:0.000.0%
Month Low:0.00